Martin Hochheimer
Biographic Data
| ID | 7836966 |
|---|---|
| NAME | Martin Hochheimer |
| GIVEN NAMES | Martin |
| FAMILY NAME | Hochheimer |
| SIGNATURE | HOCHHEIMER M |
| AFFILIATIONS | Johns Hopkins University |
| ORCID | 0000-0001-6644-4841 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Transgender individuals are at higher risk for suicidal ideation and preparation than cisgender individuals in substance use treatment
This study is a first step into understanding gender minority population experiences during SUD treatment. While there was no significant difference between the cisgender and transgender samples on most variables, there was an elevated prevalence of suicidal ideation and behaviors in the transgender sample, which warrants further investigation
Risk of acute care incidents for people treated for opioid use disorder with extended-release naltrexone and buprenorphine
Buprenorphine treatment has an established history of reducing opioid overdoses; however, extended-release naltrexone does not have the same track record. This study evaluates the risk of patients with opioid use disorder experiencing an acute-care incident treated with extended-release naltrexone compared to those treated with buprenorphine. A generalized estimating equation was used to estimate the association of days in treatment with extended…
No prominent works on this page.
Transgender individuals are at higher risk for suicidal ideation and preparation than cisgender individuals in substance use treatment
This study is a first step into understanding gender minority population experiences during SUD treatment. While there was no significant difference between the cisgender and transgender samples on most variables, there was an elevated prevalence of suicidal ideation and behaviors in the transgender sample, which warrants further investigation
Risk of acute care incidents for people treated for opioid use disorder with extended-release naltrexone and buprenorphine
Buprenorphine treatment has an established history of reducing opioid overdoses; however, extended-release naltrexone does not have the same track record. This study evaluates the risk of patients with opioid use disorder experiencing an acute-care incident treated with extended-release naltrexone compared to those treated with buprenorphine. A generalized estimating equation was used to estimate the association of days in treatment with extended…
Medicine (2 works) · Psychiatry (2 works) · Suicide and Self-Harm Studies (2 works) · Anesthesia (1 works) · Buprenorphine (1 works) · Clinical Psychology (1 works) · Clinical Psychology (1 works) · Emergency Medicine (1 works) · Environmental health (1 works) · Internal Medicine (1 works)